BioRestorative Therapies, Inc. BRTX
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 8.59% | -58.61% | -31.34% | -183.12% | -121.20% |
| Total Depreciation and Amortization | 6.21% | 11.00% | 14.39% | 15.98% | 17.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -156.45% | 263.92% | -35.70% | 118.75% | 330.26% |
| Change in Net Operating Assets | 20.65% | 4,462.72% | 626.45% | 1,238.77% | 302.38% |
| Cash from Operations | -35.97% | -31.09% | -43.52% | -36.97% | -36.47% |
| Capital Expenditure | 44.11% | -9.32% | 70.21% | 8.45% | -28.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.70% | 1,352.15% | 960.21% | 464.04% | 293.76% |
| Cash from Investing | -3.98% | 1,629.01% | 828.09% | 438.12% | 285.27% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 307.22% | -61.38% | -65.20% | -72.01% | -82.57% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.22% | 62.02% | -3,683.86% | -3,462.78% | -7,985.26% |
| Cash from Financing | 550.46% | -61.32% | -76.21% | -80.36% | -90.34% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,527.48% | 386.27% | 9.91% | -261.57% | 110.01% |